Structure |
Chemical Name |
CAS |
MF |
 |
Aprepitant Impurity 22 |
934540-48-4 |
C20H16F7NO2 |
 |
Aprepitant Impurity 9 |
219821-37-1 |
C24H25F7N4O4 |
 |
Aprepitant Impurity 28 |
|
|
 |
(3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
1428118-12-0 |
C37H43FN2O5 |
 |
Aprepitant Impurity 53 |
|
|
 |
亜りん酸トリベンジル |
15205-57-9 |
C21H21O3P |
 |
1-(2-O,3-O,5-O-トリアセチル-β-D-アラビノフラノシル)-2,4(1H,3H)-ピリミジンジオン |
14057-18-2 |
C15H18N2O9 |
 |
Reaxys ID: 3623864 |
129385-61-1 |
C17H10ClNO3 |
 |
(1S,2S,3S)-Aprepitant |
1242175-40-1 |
C23H21F7N4O3 |
 |
Aprepitant Impurity 3 |
|
|
 |
Aprepitant Impurity 12 |
172673-23-3 |
C23H21F7N4O4 |
 |
Aprepitant Impurity 18 |
|
|
 |
Aprepitant Impurity 14 |
|
|
 |
4-(3-クロロ-2-ヒドロキシプロポキシ)ベンゼンアセトアミド (ATENOLOL IMPURITY D) |
115538-83-5 |
C11H14ClNO3 |
 |
(3S,5S)-Atorvastatin sodium salt |
501121-34-2 |
C33H35FN2O5 |
 |
(3S,5S)-アトルバスタチンアセトニドTERT-ブチルチルエステル |
472967-95-6 |
C40H47FN2O5 |
 |
Nsc529487 |
3310-47-2 |
C9H13N3O6 |
![(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride](/CAS/20150408/GIF/1333998-21-2.gif) |
(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride |
1333998-21-2 |
C20H19ClF7NO2 |
 |
Atorvastatin Oxirane Impurity |
1246818-88-1 |
C26H24FNO3 |
![アトルバスタチン関連化合物B (3S,5R ISOMER, OR (3S,5R)-7-[3-(フェニルカルバモイル)-5-(4-フルオロフェニル)-2-イソプロピル-4-フェニル-1H-ピロール-1-イル]-3,5-ジヒドロキシヘプタン酸カ](/CAS/GIF/887196-25-0.gif) |
アトルバスタチン関連化合物B (3S,5R ISOMER, OR (3S,5R)-7-[3-(フェニルカルバモイル)-5-(4-フルオロフェニル)-2-イソプロピル-4-フェニル-1H-ピロール-1-イル]-3,5-ジヒドロキシヘプタン酸カ |
887196-25-0 |
C33H34CaFN2O5+ |
 |
Atorvastatin Dehydro Lactone |
442851-50-5 |
C33H31FN2O3 |
 |
アトルバスタチンラクタムラクトン |
1795791-15-9 |
C33H31FN2O5 |
 |
Aprepitant EP Impurity C |
2208275-99-2 |
C29H25F7N4O3 |
 |
Atorvastatin 2-Fluoro t-Butyl Ester |
1099474-28-8 |
C40H47FN2O5 |
 |
r-Cytidine |
13913-16-1 |
C9H13N3O5 |
 |
Aprepitant Impurity 15 |
1447693-83-5 |
C20H19ClF7NO2 |
 |
Aprepitant Impurity 34 |
|
|
 |
Cytarabine Impurity 13 |
82855-62-7 |
C17H19N5O8 |
 |
Aprepitant iMpurity 38 |
|
|
 |
Aprepitant iMpurity 41 |
|
|
![1H-Dibenz[e,g]indole-1-heptanoic acid, 9-fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-3-[(phenylamino)carbonyl]-, (βR,δR)-](/CAS/20210305/GIF/1046533-62-3.gif) |
1H-Dibenz[e,g]indole-1-heptanoic acid, 9-fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-3-[(phenylamino)carbonyl]-, (βR,δR)- |
1046533-62-3 |
C33H33FN2O6 |
![4,4'-[[(1-メチルエチル)イミノ]ビス[(2-ヒドロキシ-3,1-プロパンジイル)オキシ]]ビス-ベンゼンアセトアミド (ATENOLOL IMPURITY F)アテノロール不純物F](/CAS/GIF/87619-83-8.gif) |
4,4'-[[(1-メチルエチル)イミノ]ビス[(2-ヒドロキシ-3,1-プロパンジイル)オキシ]]ビス-ベンゼンアセトアミド (ATENOLOL IMPURITY F)アテノロール不純物F |
87619-83-8 |
C25H35N3O6 |
 |
Aprepitant iMpurity A |
|
|
 |
Atorvastatin LactaM Phenanthrene CalciuM Salt |
1046378-58-8 |
C33H35CaFN2O6 |
![1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-pyrimidine-2,4-dione](/CAS/20180601/GIF/69321-95-5.gif) |
1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-pyrimidine-2,4-dione |
69321-95-5 |
C9H12N2O7 |
 |
Aprepitant Impurity 23 |
|
|
 |
(3R,5R)-tert-butyl 7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
2588261-40-7 |
C37H42F2N2O5 |
 |
Aprepitant |
1242175-36-5 |
C20H18F7NO2 |
 |
Cytarabine Impurity 10 |
84902-98-7 |
C4H6N2O3 |
 |
3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(3-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
![2-[4-[(2RS)-2-HYDROXY-3[(1-METHYLETHYL)AMINO]PROPOXY]PHENYL]ACETONITRILE](/CAS/GIF/29277-73-4.gif) |
2-[4-[(2RS)-2-HYDROXY-3[(1-METHYLETHYL)AMINO]PROPOXY]PHENYL]ACETONITRILE |
29277-73-4 |
C14H20N2O2 |
![4-メチル-3-[[1-オキソ-2-(プロピルアミノ)プロピル]アミノ]-2-チオフェンカルボン酸](/CAS/GIF/114176-52-2.gif) |
4-メチル-3-[[1-オキソ-2-(プロピルアミノ)プロピル]アミノ]-2-チオフェンカルボン酸 |
114176-52-2 |
C12H18N2O3S |
 |
10-trans-Atorvastatin Acetonide tert-Butyl Ester |
1105067-90-0 |
C40H47FN2O5 |
 |
(4S,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester |
186508-95-2 |
C14H23NO4 |
 |
4,4'-(2-HYDROXY-1,3-PROPANDIYLDIOXY)BIS(2-PHENYLACETAMIDE) |
141650-31-9 |
C19H22N2O5 |
 |
Articaine IMpurity F (Articaine Acid PropionaMide HCl) |
|
|
 |
Aprepitant Impurity 6 |
170902-81-5 |
C23H21F7N4O3 |
 |
(3S,5S)-Atorvastatin (sodium salt) |
1428118-38-0 |
C33H36FN2NaO5 |
 |
Aprepitant Impurity 19 |
1333995-14-4 |
|
 |
Aprepitant Impurity 15 |
|
|
 |
Aprepitant iMpurity 45 |
|
|
![3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)-](/CAS/20211123/GIF/1193817-52-5.gif) |
3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)- |
1193817-52-5 |
C33H35FN2O7 |
 |
3-(((3R)-3-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)-1,4-dioxan-2-ylamino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
![rel-5-クロロ-2,3,3aα*,12bα*-テトラヒドロ-2-メチル-1H-ジベンゾ[2,3:6,7]オキセピノ[4,5-c]ピロール](/CAS/20180808/GIF/65621-78-5.gif) |
rel-5-クロロ-2,3,3aα*,12bα*-テトラヒドロ-2-メチル-1H-ジベンゾ[2,3:6,7]オキセピノ[4,5-c]ピロール |
65621-78-5 |
C17H16ClNO |
 |
Avibactam Impurity 15 |
1416134-60-5 |
C15H20N2O3 |
 |
Difluoro Atorvastatin Acetonide tert-Butyl Ester |
693793-87-2 |
C40H46F2N2O5 |
 |
3-Oxo Atorvastatin tert-Butyl Ester |
134394-98-2 |
C37H41FN2O5 |
![(4R,6S)-6-(2-[15N]アミノエチル)-2,2-ジメチル-1,3-ジオキサン-4-酢酸1,1-ジメチルエチル](/CAS/20180629/GIF/CB03956533.gif) |
(4R,6S)-6-(2-[15N]アミノエチル)-2,2-ジメチル-1,3-ジオキサン-4-酢酸1,1-ジメチルエチル |
|
C14H27NO4 |
 |
Axitinib Impurity 13 |
|
|
 |
Axitinib Impurity 18 |
|
|
 |
Avibactam Impurity |
2064219-26-5 |
C7H12N3NaO6S |
 |
Atorvastatin Impurity E Intermediate |
|
|
 |
Avibactam sodium Impurity CIS |
|
|
 |
(3R,5R)-7-(1-((3R,5R)-6-carboxy-3,5-dihydroxyhexyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxamido)-3,5-dihydroxyheptanoic acid |
|
|
 |
Axitinib Impurity D |
1443118-72-6 |
C29H25N5OS |
 |
Atorvastatin Impurity 30 |
666714-64-3 |
C26H23FN2O |
 |
Avibactam Impurity R |
|
|
 |
Avibactam Impurity X |
|
|
 |
Avibactam Impurity 38 |
2241730-86-7 |
C20H29BrN2O5 |
 |
Atorvastatin Impurity 34 |
|
C66H68CaF2N4O10 |
 |
Axitinib Impurity 6 |
|
|
 |
ethyl 2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan- 4-yl)acetate |
616201-27-5 |
C38H43FN2O5 |
 |
((((3R,6S)-6-carbamoylpiperidin-3-yl)(ethoxycarbonyl)amino)oxy)sulfonic acid |
|
|
 |
(S)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl) ethyl)-5,6-dihydro-2H-pyran-2-one |
|
|
 |
Atorvastatin Impurity N(Calcium salt |
|
|
 |
(4S,TRANS)-1,1-ジメチルエチル-6-アミノエチル-2,2-ジメチル-1,3-ジオキサン-4-アセタート |
1105067-89-7 |
C14H27NO4 |
 |
Axitinib Impurity a |
1347304-18-0 |
C22H18N4O2S |
 |
Axitinib Impurity 2 |
1428728-83-9 |
C44H36N8O2S2 |
 |
Avibactam Impurity 3(2R,5S) |
1383814-68-3 |
C7H12N3NaO6S |
 |
Atorvastatin Impurity 22 |
1821498-27-4 |
C27H30FNO6 |
![propan-2-yl 2-[(4R,6R)-6-{2-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetate](/CAS/20200331/GIF/1112262-71-1.gif) |
propan-2-yl 2-[(4R,6R)-6-{2-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxan-4-yl]acetate |
1112262-71-1 |
C39H45FN2O5 |
 |
Avibactam Impurity 45 |
2064219-20-9 |
C23H46N4O6S |
 |
Axitinib Impurity 3 |
|
|
 |
((3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenyl
carbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate)calcium(II)
|
|
C66H68CaF2N4O10 |
 |
Acemetacin Impurity C |
|
|
![(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl methyl sulfate](/) |
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl methyl sulfate |
|
|
![Heptanoic acid, 7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3R,5R)-](/CAS/20200611/GIF/2409556-65-4.gif) |
Heptanoic acid, 7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3R,5R)- |
2409556-65-4 |
C44H56FN3O8 |
![Benzamide, 2-[(1-acetyl-3-iodo-1H-indazol-6-yl)thio]-N-methyl-](/CAS/20210111/GIF/1639138-00-3.gif) |
Benzamide, 2-[(1-acetyl-3-iodo-1H-indazol-6-yl)thio]-N-methyl- |
1639138-00-3 |
C17H14IN3O2S |
 |
Atorvastatin Impurity 45 (Sodium Salt) |
|
|
 |
Acemetacin Impurity F |
|
|
![1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate](/CAS/20180702/GIF/1192651-80-1.gif) |
1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate |
1192651-80-1 |
C23H46N4O6S |
![Acemetacin EP Impurity F/Carboxymethyl Acemetacin/[[[[[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl]oxy]acetyl]oxy]acetic acid](/CAS/20210111/GIF/76812-49-2.gif) |
Acemetacin EP Impurity F/Carboxymethyl Acemetacin/[[[[[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl]oxy]acetyl]oxy]acetic acid |
76812-49-2 |
C23H20ClNO8 |
 |
Avibactam Impurity A |
|
|
 |
Avibactam Impurity F |
|
|
 |
Axitinib Impurity 14 |
|
|
 |
2-((4S,6S)-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
2165770-84-1 |
C10H19NO4 |
 |
Avibactam sodium Impurity CEA |
|
|
![1,3-Dioxane-4-acetic acid, 6-[2-[3-[[[2-[(4R,6R)-6-[2-(1,1-dimethylethoxy)-2-oxoethyl]-2,2-dimethyl-1,3-dioxan-4-yl]ethyl]amino]carbonyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-4-phenyl-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6R)-](/CAS/20210305/GIF/1229658-18-7.gif) |
1,3-Dioxane-4-acetic acid, 6-[2-[3-[[[2-[(4R,6R)-6-[2-(1,1-dimethylethoxy)-2-oxoethyl]-2,2-dimethyl-1,3-dioxan-4-yl]ethyl]amino]carbonyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-4-phenyl-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R,6R)- |
1229658-18-7 |
C48H67FN2O9 |
 |
tert-butyl (3R,5R)-7-(1-((3R,5R)-7-(tert-butoxy)-3,5-dihydroxy-7-oxoheptyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxamido)-3,5-dihydroxyheptanoate |
|
|
 |
アトルバスタチンアセトニド |
581772-29-4 |
C36H39FN2O5 |